Molecule Details
| InChIKey | OQHPHGZWSTYMIQ-SFHVURJKSA-N |
|---|---|
| Compound Name | 4-[(2S)-1-[2-[2-(3-chloro-4-methoxyphenyl)ethyl]-6-(3,5-dimethyl-1,2-oxazol-4-yl)benzimidazol-1-yl]propan-2-yl]morpholine |
| Canonical SMILES | COc1ccc(CCc2nc3ccc(-c4c(C)noc4C)cc3n2C[C@H](C)N2CCOCC2)cc1Cl |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 3 |
| Pfam Stratification | Homologous |
| Avg pChEMBL | 7.14 |
| Source | ChEMBL |
2D Structure
Activity Profile
Target Activities (3)
| Target | Gene | Organism | Category | Pfam | pChEMBL | Type | Source |
|---|---|---|---|---|---|---|---|
| Q09472 | EP300 | Homo sapiens | Human | PF00439 PF09030 PF08214 PF02172 PF23570 PF06001 PF02135 PF00569 | 7.7 | IC50 | ChEMBL |
| Q92793 | CREBBP | Homo sapiens | Human | PF00439 PF09030 PF08214 PF02172 PF23570 PF06001 PF02135 PF00569 | 7.7 | IC50 | ChEMBL |
| O60885 | BRD4 | Homo sapiens | Human | PF17035 PF17105 PF00439 | 6.1 | IC50 | ChEMBL |